Clinical trialUNITERAREMay 6
New Recruiting Trial: A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
Researchers are looking for children and young adults with a type of blood cancer called B-cell acute lymphoblastic leukemia (ALL) who have gone into remission after receiving CAR-T cell therapy. This study will use advanced genetic testing to monitor how well the patient's immune system recovers after treatment and help doctors decide on the best follow-up care plan.
WHY IT MATTERSThis trial offers a personalized monitoring approach for ALL patients in remission after CAR-T therapy, potentially reducing unnecessary treatments while catching early signs of relapse through genetic testing rather than standard methods alone.